1. Home
  2. ONCO vs SPRC Comparison

ONCO vs SPRC Comparison

Compare ONCO & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Onconetix Inc.

ONCO

Onconetix Inc.

N/A

Current Price

$1.89

Market Cap

4.3M

Sector

Health Care

ML Signal

N/A

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

N/A

Current Price

$1.55

Market Cap

4.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ONCO
SPRC
Founded
2018
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
4.0M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
ONCO
SPRC
Price
$1.89
$1.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
39.7K
3.5M
Earning Date
11-13-2025
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,223,751.00
$1,306,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
187.98
52 Week Low
$1.90
$1.55
52 Week High
$179.35
$37.59

Technical Indicators

Market Signals
Indicator
ONCO
SPRC
Relative Strength Index (RSI) 34.05 31.44
Support Level $2.53 $1.55
Resistance Level $3.22 $2.02
Average True Range (ATR) 0.32 0.24
MACD -0.06 0.01
Stochastic Oscillator 0.00 1.16

Price Performance

Historical Comparison
ONCO
SPRC

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: